These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
478 related articles for article (PubMed ID: 10598586)
1. A fusion protein of the estrogen receptor (ER) and nuclear receptor corepressor (NCoR) strongly inhibits estrogen-dependent responses in breast cancer cells. Chien PY; Ito M; Park Y; Tagami T; Gehm BD; Jameson JL Mol Endocrinol; 1999 Dec; 13(12):2122-36. PubMed ID: 10598586 [TBL] [Abstract][Full Text] [Related]
2. Differential recruitment of coregulator proteins steroid receptor coactivator-1 and silencing mediator for retinoid and thyroid receptors to the estrogen receptor-estrogen response element by beta-estradiol and 4-hydroxytamoxifen in human breast cancer. Fleming FJ; Hill AD; McDermott EW; O'Higgins NJ; Young LS J Clin Endocrinol Metab; 2004 Jan; 89(1):375-83. PubMed ID: 14715875 [TBL] [Abstract][Full Text] [Related]
3. Estrogen response element-dependent regulation of transcriptional activation of estrogen receptors alpha and beta by coactivators and corepressors. Klinge CM; Jernigan SC; Mattingly KA; Risinger KE; Zhang J J Mol Endocrinol; 2004 Oct; 33(2):387-410. PubMed ID: 15525597 [TBL] [Abstract][Full Text] [Related]
4. A novel natural mutation in the thyroid hormone receptor defines a dual functional domain that exchanges nuclear receptor corepressors and coactivators. Tagami T; Gu WX; Peairs PT; West BL; Jameson JL Mol Endocrinol; 1998 Dec; 12(12):1888-902. PubMed ID: 9849963 [TBL] [Abstract][Full Text] [Related]
5. Associations and interactions between Ets-1 and Ets-2 and coregulatory proteins, SRC-1, AIB1, and NCoR in breast cancer. Myers E; Hill AD; Kelly G; McDermott EW; O'Higgins NJ; Buggy Y; Young LS Clin Cancer Res; 2005 Mar; 11(6):2111-22. PubMed ID: 15788656 [TBL] [Abstract][Full Text] [Related]
6. Mechanistic aspects of estrogen receptor activation probed with constitutively active estrogen receptors: correlations with DNA and coregulator interactions and receptor conformational changes. Lazennec G; Ediger TR; Petz LN; Nardulli AM; Katzenellenbogen BS Mol Endocrinol; 1997 Aug; 11(9):1375-86. PubMed ID: 9259327 [TBL] [Abstract][Full Text] [Related]
8. Constitutively active human estrogen receptors containing amino acid substitutions for tyrosine 537 in the receptor protein. Weis KE; Ekena K; Thomas JA; Lazennec G; Katzenellenbogen BS Mol Endocrinol; 1996 Nov; 10(11):1388-98. PubMed ID: 8923465 [TBL] [Abstract][Full Text] [Related]
9. Gene silencing by chicken ovalbumin upstream promoter-transcription factor I (COUP-TFI) is mediated by transcriptional corepressors, nuclear receptor-corepressor (N-CoR) and silencing mediator for retinoic acid receptor and thyroid hormone receptor (SMRT). Shibata H; Nawaz Z; Tsai SY; O'Malley BW; Tsai MJ Mol Endocrinol; 1997 Jun; 11(6):714-24. PubMed ID: 9171235 [TBL] [Abstract][Full Text] [Related]
10. Role of estrogen receptor ligand and estrogen response element sequence on interaction with chicken ovalbumin upstream promoter transcription factor (COUP-TF). Klinge CM J Steroid Biochem Mol Biol; 1999 Nov; 71(1-2):1-19. PubMed ID: 10619353 [TBL] [Abstract][Full Text] [Related]
11. The interaction of the vitamin D receptor with nuclear receptor corepressors and coactivators. Tagami T; Lutz WH; Kumar R; Jameson JL Biochem Biophys Res Commun; 1998 Dec; 253(2):358-63. PubMed ID: 9878542 [TBL] [Abstract][Full Text] [Related]
12. Synergistic activation of functional estrogen receptor (ER)-alpha by DNA methyltransferase and histone deacetylase inhibition in human ER-alpha-negative breast cancer cells. Yang X; Phillips DL; Ferguson AT; Nelson WG; Herman JG; Davidson NE Cancer Res; 2001 Oct; 61(19):7025-9. PubMed ID: 11585728 [TBL] [Abstract][Full Text] [Related]
13. Contrasting effects of prenyltransferase inhibitors on estrogen-dependent cell cycle progression and estrogen receptor-mediated transcriptional activity in MCF-7 cells. Doisneau-Sixou SF; Cestac P; Chouini S; Carroll JS; Hamilton AD; Sebti SM; Poirot M; Balaguer P; Faye JC; Sutherland RL; Favre G Endocrinology; 2003 Mar; 144(3):989-98. PubMed ID: 12586776 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of the dihydrotestosterone-activated androgen receptor by nuclear receptor corepressor. Cheng S; Brzostek S; Lee SR; Hollenberg AN; Balk SP Mol Endocrinol; 2002 Jul; 16(7):1492-501. PubMed ID: 12089345 [TBL] [Abstract][Full Text] [Related]
15. The specificity of interactions between nuclear hormone receptors and corepressors is mediated by distinct amino acid sequences within the interacting domains. Cohen RN; Brzostek S; Kim B; Chorev M; Wondisford FE; Hollenberg AN Mol Endocrinol; 2001 Jul; 15(7):1049-61. PubMed ID: 11435607 [TBL] [Abstract][Full Text] [Related]
16. Repression of endogenous estrogen receptor activity in MCF-7 human breast cancer cells by dominant negative estrogen receptors. Ince BA; Schodin DJ; Shapiro DJ; Katzenellenbogen BS Endocrinology; 1995 Aug; 136(8):3194-9. PubMed ID: 7628351 [TBL] [Abstract][Full Text] [Related]
17. Expression of steroid receptor coactivators and corepressors in human endometrial hyperplasia and carcinoma with relevance to steroid receptors and Ki-67 expression. Uchikawa J; Shiozawa T; Shih HC; Miyamoto T; Feng YZ; Kashima H; Oka K; Konishi I Cancer; 2003 Nov; 98(10):2207-13. PubMed ID: 14601091 [TBL] [Abstract][Full Text] [Related]
18. Expression of sex steroid receptors and their co-factors in normal and malignant breast tissue: AIB1 is a carcinoma-specific co-activator. Hudelist G; Czerwenka K; Kubista E; Marton E; Pischinger K; Singer CF Breast Cancer Res Treat; 2003 Mar; 78(2):193-204. PubMed ID: 12725419 [TBL] [Abstract][Full Text] [Related]
19. Functional synergy between the transcription factor Sp1 and the estrogen receptor. Porter W; Saville B; Hoivik D; Safe S Mol Endocrinol; 1997 Oct; 11(11):1569-80. PubMed ID: 9328340 [TBL] [Abstract][Full Text] [Related]
20. Dissociation of steroid receptor coactivator 1 and nuclear receptor corepressor recruitment to the human glucocorticoid receptor by modification of the ligand-receptor interface: the role of tyrosine 735. Stevens A; Garside H; Berry A; Waters C; White A; Ray D Mol Endocrinol; 2003 May; 17(5):845-59. PubMed ID: 12569182 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]